PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, University of Wisconsin-Madison, School of Medicine & Public Health Madison, Madison, Wisconsin, USA.\', \'School of Pharmacy University of Wisconsin-Madison, Madison, Wisconsin, USA.\', \'Division of Gastroenterology and Hepatology, NYU Langone Health, New York, New York, USA.\', \'Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.\', \'University of Maryland School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Baltimore, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ibd/izab114
?:doi
?:hasPublicationType
?:journal
  • Inflammatory bowel diseases
is ?:pmid of
?:pmid
?:pmid
  • 34013958
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.511
?:rankingScore_hIndex
  • 121
?:title
  • Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all